A Case Report of Chemotherapy-Induced Alopecia Treated with Bojungikki-Tang

    Sanghun Lee
    Image
    Studysummary This case study reports that a patient receiving Bojungikki-tang alongside chemotherapy showed improvement in hair loss despite ongoing treatment, suggesting a potential benefit for chemotherapy-induced alopecia. Our plain-language summary of this paper — not a Tressless recommendation.
    This case study reported on a 70-year-old female with chemotherapy-induced alopecia due to treatment for cholangiocarcinoma and liver metastasis. She experienced various side effects from chemotherapy, including hair loss. Bojungikki-tang was administered to address her general weakness and fatigue. After three months, her hair loss improved, and new hair growth was observed with a dark color, despite ongoing chemotherapy. However, Bojungikki-tang did not alleviate other symptoms like bone marrow suppression and peripheral numbness. This case suggested that Bojungikki-tang might have a beneficial effect on chemotherapy-induced alopecia.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results